NuScale Power faces a bearish outlook from UBS as analysts highlight the gap between regulatory progress and the commercial execution needed to turn modular reactor technology into profitable power plants.
UBS downgraded NuScale Power to Sell with a $6 price target, citing execution risks and no concrete client commitments.
UBS has downgraded NuScale Power (SMR) to Sell with a $6 price target, warning of significant execution risks and a lack of concrete client commitments. While the company has secured regulatory approval for its reactor design and maintains a strong cash position, analysts remain concerned about the long timeline to commercialization and the firm's ongoing cash burn.
UBS cited execution risks, a long development timeline, and a lack of concrete client commitments, suggesting the company faces significant challenges in bringing its reactor technology to commercial operation.
The primary concern is the company's high cash burn rate, with UBS forecasting $700 million in cumulative cash usage from 2026 through 2028, which necessitates continued reliance on capital markets.